Is EVO ICL Right for You?
Are you tired of struggling with the daily hassle of corrective lenses or glasses? Or looking for an alternative option to LASIK? If you answered “yes” to either of these questions, we may have the ideal vision corrective solution for you. EVO ICL (EVO) are implantable lenses that are an ideal alternative to more traditional vision correction solutions. Get to know a little bit more about this FDA approved groundbreaking procedure and find out how to find a doctor near you.
What is ICL?
ICL, also known as Implantable Collamer Lenses, is a refractive procedure used to correct the common problem of nearsightedness or myopia. Simply put, ICL is a removable lens implant that is a common and attractive alternative to LASIK or other similar procedures.
Collamer technology is an ideal solution for correcting one’s vision and offers patients many unique characteristics, such as being:
- Biocompatible
- Soft and pliable
- Protective against harmful UV Rays
Are you an ideal candidate for EVO ICL?
Ideal EVO ICL candidates are:
- Between the ages of 21 – 45
- Nearsighted with mild to severe myopia (-3D to -20D)
- Have not had a change in prescription of more than .5D in a year
- Looking for an alternative procedure that does not create dry eye
- Have minor or no astigmatism (2.5D of less)
What is involved with EVO ICL?
EVO ICL procedures are both quick and painless. To begin, pre-op numbing medication is placed into both eyes. Next, a small incision is made at the base of the cornea to prep the eye for the implant. The lens is then folded and inserted into the incision and adjusted to ensure proper positioning. The whole procedure usually takes no longer than 30 minutes. Most patients notice an immediate improvement to their vision following their procedure.
The difference is clear. EVO ICL can be an excellent alternative to LASIK or corrective lenses, allowing patients to see the world naturally with their own eyes. Discover the endless possibilities of EVO ICL today by finding an EVO ICL certified doctor near you. Contact a surgeon to ask any questions you may have regarding the procedure and whether ICL is right for you.
Important Safety Information
The EVO Visian ICL Lens is intended for the correction of moderate to high nearsightedness. EVO Visian ICL and EVO Visian TICL surgery is intended to safely and effectively correct nearsightedness between -3.0 D to -15.0 D, the reduction in nearsightedness up to -20.0 D and treatment of astigmatism from 1.0 D to 4.0 D. If you have nearsightedness within these ranges, EVO Visian ICL surgery may improve your distance vision without eyeglasses or contact lenses. Because the EVO Visian ICL corrects for distance vision, it does not eliminate the need for reading glasses, you may require them at some point, even if you have never worn them before.
Implantation of the EVO Visian ICL is a surgical procedure, and as such, carries potentially serious risks. Please discuss the risks with your eye care professional. Complications, although rare, may include need for additional surgical procedures, inflammation, loss of cells from the back surface of the cornea, increase in eye pressure, and cataracts.
You should NOT have EVO Visian ICL surgery if:
- Your doctor determines that the shape of your eye is not an appropriate fit for the EVO Visian ICL
- You are pregnant or nursing
- You have moderate to severe damage to the optic nerve caused by increased pressure (glaucoma)
- You do not meet the minimum endothelial cell density for your age at the time of implantation as determined by your eye doctor
- Your vision is not stable as determined by your eye doctor
Before considering EVO Visian ICL surgery you should have a complete eye examination and talk with your eye care professional about EVO Visian ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery. For additional information with potential benefits, risks and complications please visit DiscoverICL.com.
Select Your Region
Latin America
References
1Patient Survey, STAAR Surgical ICL Data Registry, 2018
2Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46.
3Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.
4Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.
5aLee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.
5bParkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.